Survodutide mastery course
Unit 5 of 12

Obesity: the weight-loss evidence

Obesity is survodutide marquee program, and this unit walks the actual numbers rather than the headlines. We start with…

From a dose-finding trial to a Phase 3 result

Obesity is survodutide marquee program, and this unit walks the actual numbers rather than the headlines. We start with the Phase 2 dose-finding trial that mapped weight loss against dose, then the SYNCHRONIZE-1 Phase 3 readout that confirmed a real obesity drug, and finally where survodutide lands beside the class leaders on the cardiometabolic outcomes that matter most.

Throughout, we keep the estimand and timepoint attached to every figure, because a percentage without its trial and its definition is how weight-loss claims get inflated online.

Key terms

The Phase 2 dose-response


The SYNCHRONIZE-1 readout


How many people responded


Weight loss against the class


Beyond the scale